Your browser doesn't support javascript.
A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe.
Borobia, Alberto M; Carcas, Antonio J; Arnalich, Francisco; Álvarez-Sala, Rodolfo; Monserrat-Villatoro, Jaime; Quintana, Manuel; Figueira, Juan Carlos; Torres Santos-Olmo, Rosario M; García-Rodríguez, Julio; Martín-Vega, Alberto; Buño, Antonio; Ramírez, Elena; Martínez-Alés, Gonzalo; García-Arenzana, Nicolás; Núñez, M Concepción; Martí-de-Gracia, Milagros; Moreno Ramos, Francisco; Reinoso-Barbero, Francisco; Martin-Quiros, Alejandro; Rivera Núñez, Angélica; Mingorance, Jesús; Carpio Segura, Carlos J; Prieto Arribas, Daniel; Rey Cuevas, Esther; Prados Sánchez, Concepción; Rios, Juan J; Hernán, Miguel A; Frías, Jesús; Arribas, José R.
  • Borobia AM; Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Carcas AJ; Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Arnalich F; Internal Medicine Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Álvarez-Sala R; Pneumology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Monserrat-Villatoro J; Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Quintana M; Intensive Care Unit, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Figueira JC; Intensive Care Unit, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Torres Santos-Olmo RM; Emergency Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • García-Rodríguez J; Microbiology Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Martín-Vega A; CSUR Coordination, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Buño A; Laboratory Medicine Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Ramírez E; Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Martínez-Alés G; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, USA.
  • García-Arenzana N; Preventive Medicine Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Núñez MC; Risk Prevention Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Martí-de-Gracia M; Emergency Radiology Unit, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Moreno Ramos F; Pharmacy Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Reinoso-Barbero F; Anesthesiology Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Martin-Quiros A; Emergency Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Rivera Núñez A; Emergency Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Mingorance J; Microbiology Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Carpio Segura CJ; Pneumology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Prieto Arribas D; Laboratory Medicine Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Rey Cuevas E; Nursing Department, La Paz University Hospital-IdiPAZ, 28046 Madrid, Spain.
  • Prados Sánchez C; Pneumology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Rios JJ; Internal Medicine Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Hernán MA; Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology, Boston, MA 02115, USA.
  • Frías J; Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
  • Arribas JR; Internal Medicine Department, La Paz University Hospital-IdiPAZ, Universidad Autónoma de Madrid, 28046 Madrid, Spain.
J Clin Med ; 9(6)2020 Jun 04.
Article in English | MEDLINE | ID: covidwho-593078
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in January 2020, the epidemic has grown rapidly, with the greatest impact on the region of Madrid. This article describes the first 2226 adult patients with COVID-19, consecutively admitted to La Paz University Hospital in Madrid.

METHODS:

Our cohort included all patients consecutively hospitalized who had a final outcome (death or discharge) in a 1286-bed hospital of Madrid (Spain) from 25 February (first case admitted) to 19 April 2020. The data were manually entered into an electronic case report form, which was monitored prior to the analysis.

RESULTS:

We consecutively included 2226 adult patients admitted to the hospital who either died (460) or were discharged (1766). The patients' median age was 61 years, and 51.8% were women. The most common comorbidity was arterial hypertension (41.3%), and the most common symptom on admission was fever (71.2%). The median time from disease onset to hospital admission was 6 days. The overall mortality was 20.7% and was higher in men (26.6% vs. 15.1%). Seventy-five patients with a final outcome were transferred to the intensive care unit (ICU) (3.4%). Most patients admitted to the ICU were men, and the median age was 64 years. Baseline laboratory values on admission were consistent with an impaired immune-inflammatory profile.

CONCLUSIONS:

We provide a description of the first large cohort of hospitalized patients with COVID-19 in Europe. Advanced age, male sex, the presence of comorbidities and abnormal laboratory values were more common among the patients with fatal outcomes.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2020 Document Type: Article Affiliation country: Jcm9061733

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2020 Document Type: Article Affiliation country: Jcm9061733